Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lawrence Kenyon Insider Profile
4 Followers
Lawrence Kenyon, CFO & Sec at Insys Therapeutics, holds 0.00 shares in Insys Therapeutics (Ticker: INSYQ), holds 5.95K shares in Outlook Therapeutics (Ticker: OTLK), holds 93.48K shares in Oncobiologics Inc (Ticker: ONSIU). Most recently, Lawrence Kenyon ― shares of Insys Therapeutics on ― for an estimated value of ―.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-52.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Lawrence Kenyon's holdings
Insider Roles
CFO, Director
Roles that Lawrence Kenyon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 20, 2021 - Apr 20, 2022
Return:+1.60%
The most profitable trade made by Lawrence Kenyon
Lawrence Kenyon's Trading History
Insys Therapeutics
―
―
―
$0.00
Oncobiologics Inc
Dec 22, 2016
―
Uninformative Buy
―
$441.22K
Outlook Therapeutics
Sep 30, 2024
CFO, Director
Informative Buy
28.40K
$8.56K
Par Pharmaceutical Cos. Inc.
Aug 04, 2010
―
Uninformative Sell
169.79K
―
List of latest transactions for each holding click on a transaction to see Lawrence Kenyon's performance on stock
You May Also Like
Lawrence Kenyon insider profile FAQ
What is the percentage of profitable transactions made by Lawrence Kenyon?
The percentage of profitable transactions made by Lawrence Kenyon is 33%.
What is the average return per transaction made by Lawrence Kenyon?
The average return per transaction made by Lawrence Kenyon is -52.60%.
What stocks does Lawrence Kenyon hold?
Lawrence Kenyon holds: INSYQ, ONSIU, OTLK, PRX stocks.
What was Lawrence Kenyon’s latest transaction?
Lawrence Kenyon latest transaction was an Uninformative Buy of ―.
What was Lawrence Kenyon's most profitable transaction?
Lawrence Kenyon’s most profitable transaction was an Informative Buy of OTLK stock on April 20, 2021. The return on the trade was 1.60%.
What is Lawrence Kenyon's role in Insys Therapeutics?
Lawrence Kenyon's role in Insys Therapeutics is CFO & Sec.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.